-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Monthly Archives: February 2008
Get the Deep Dish on Biotech at the World Congress
Chicago is my kinda town. Meet me there April 27-30 for the World Congress on Industrial Biotechnology and Bioprocessing. There’s a great lineup of sessions and speakers highlighting the latest in industrial biotechnology. Now in its fifth year, the Congress continues to grow in size and scope. This event has something for everyone – session tracks will cover relevant topics in the areas of biofuels and bioenergy; renewable feedstocks; renewable chemicals and biomaterials; fine chemicals; Read More >
Boston in the Spring Time is Even More Lovely with BIO
BIO will debut a new conference in Boston April 22-23. The National Venture Conference will draw early-stage, private biotech companies and healthcare venture partners. I hope to see you there, but in the meantime, check out http://bnvc.bio.org for more details in the coming months.
Biotech World to Descend on San Diego
The 2008 BIO International Convention is the place to be for anyone covering the life sciences, investments and policy. If you have attended in the past, you’ll notice a few changes – the day pattern will be Tuesday through Friday, come into town early though for the golf outing. I’ll be dragging my Patti Berg’s to California, should be fun. Check out the new program tracks – Biomarkers, Growing the Biotech Workforce, and International Case Studies. Join Read More >
From the Hill to the Street: Examining Policy Issues in Biotech
Without a supportive legislative and regulatory environment, biotech companies cannot raise the funds necessary to get a product to market. The panelists explored the pressing policy issues which could have a significant impact on the industry, from the creation of a pathway for the approval of follow-on biologics, patent reform, comparative effectiveness and the implementation of the Food and Drug Administration Amendments Act (FDAAA) which was signed into law last year. The panelists also discussed Read More >
Elusive Cancer Endpoints: How to Survive the Uncertainty
The debate surrounding cancer endpoints has focused on the issue of quality of life and progression. Panelists shared some of the challenges in assessing quality of life, since it can be a fickle and subjective process. The data can be hard to nail down since patients don’t always fill out the forms. The critical issues include survival rates, improved quality of life and progression of disease. Everything must be taken into consideration to determine endpoints, which is why Read More >
